Search clinical trials for: Gallbladder disease

Total 384779 results

Hospital de Clinicas de Porto Alegre

Unknown

Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients

Diabetes Mellitus | Microalbuminuria

Brazil
University of Medicine and Dentistry of New Jersey
Bristol-Myers Squibb

Completed

Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety

Schizophrenia | Schizoaffective Disorder | Social Anxiety Disorder

United States
University of Oxford
Merck KGaA, Darmstadt, Germany

Unknown

Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial Function

Atherosclerosis

United Kingdom
Eli Lilly and Company

Completed

Bone Effects of Teriparatide Following Alendronate

Osteoporosis

Austria, Czech Republic
Eli Lilly and Company

Completed

Raloxifene Use for The Heart

Cardiovascular Diseases | Breast Neoplasms

United States
Glostrup University Hospital, Copenhagen
Juvenile Diabetes Research Foundation

Completed

Heredity of Retinal Vessel Tortuosity

Retinopathy of Prematurity

Denmark
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine in the Treatment of Stress Urinary Incontinence.

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms

Urinary Incontinence, Stress

France, Sweden, Netherlands, Spain, Germany, South Africa, Switzerland
Eli Lilly and Company

Completed

A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.

Genital Neoplasms, Female | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Pelvic Neoplasms

United States
Eli Lilly and Company

Completed

A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer

Breast Neoplasms

United States
Eli Lilly and Company

Completed

An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Germany
Eli Lilly and Company

Completed

An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Germany
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

Inappropriate ADH Syndrome | Water Intoxication | Hyponatremias | Water-Electrolyte Imbalances

United States
Eli Lilly and Company

Completed

A Study of LY317615 in Patients With Brain Tumors

Malignant Glioma

United States
Eli Lilly and Company

Completed

A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer

Breast Cancer

Canada
Northeastern Ohio Universities College of Medicine
Pfizer; U.S. Army Medical Research and Development Command; Louis Stokes VA Medical... and other collaborators

Unknown

Restless Legs Syndrome Exercise Intervention

Restless Legs Syndrome | Insomnia
Eli Lilly and Company

Completed

Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania

Bipolar Disorder

Hungary, Australia, Greece, Russian Federation
Eli Lilly and Company

Completed

Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.

Carcinoma, Non-Small-Cell Lung

United States
Eli Lilly and Company

Completed

Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.

Attention Deficit Hyperactivity Disorder

Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company

Completed

Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma

Gastrointestinal Neoplasms

Korea, Republic of
Eli Lilly and Company

Completed

Teriparatide Use in Hip Replaced Subjects

Osteoporosis

Italy
Eli Lilly and Company

Completed

A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned

Carcinoma, Small Cell

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence

Stress Urinary Incontinence

United States, Canada
Eli Lilly and Company

Completed

A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma

Advanced Gastric Carcinoma

Italy
Eli Lilly and Company

Completed

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

Mesothelioma

Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.

Urinary Incontinence, Stress

United States, Canada, United Kingdom
Eli Lilly and Company

Completed

A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small Cell Lung

China, Taiwan, Australia, Korea, Republic of, Egypt, Romania, India, Turkey
Eli Lilly and Company

Completed

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

Mesothelioma

United States
Medical University of Vienna

Completed

Endothelin-Receptor Blockade in Coronary Heart Disease

Vascular Resistance | Coronary Vessels | Endothelins

Austria
Eli Lilly and Company

Completed

Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence

Urinary Stress Incontinence

United States, Slovenia, United Kingdom
Eli Lilly and Company

Completed

Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer

Carcinoma, Non Small Cell Lung

United States
Eli Lilly and Company

Completed

Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer

Breast Cancer | Neoplasm Metastasis

Russian Federation
Eli Lilly and Company

Completed

Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Lung Neoplasms

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence

Urinary Stress Incontinence

United States, Netherlands
Eli Lilly and Company

Completed

Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder

Bipolar Disorder

United States, Lithuania, Puerto Rico, Romania, Russian Federation
Memorial Sloan Kettering Cancer Center

Completed

Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Eli Lilly and Company

Completed

Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.

Non-Small-Cell Lung Carcinoma

Argentina, Brazil, Chile, Mexico
University of Mississippi Medical Center
Kyowa Hakko Kogyo Co., Ltd.

Completed

Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Retinal Consultants Medical Group

Completed

Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD

Macular Degeneration | Choroidal Neovascularization

United States
Eli Lilly and Company

Completed

A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer

Pancreatic Cancer

United States
Eli Lilly and Company

Completed

A Study in People With Abnormal Fat Levels in the Blood

Dyslipidemia

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)

Urinary Incontinence, Stress

Brazil, Canada, France, Germany, Italy, Mexico, Puerto Rico, Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

Urinary Incontinence Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine

Urinary Stress Incontinence

United Kingdom
Eli Lilly and Company
Aventis Pharmaceuticals

Completed

A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Italy
Eli Lilly and Company

Completed

Efficacy Study of LY2422347 to Treat Insomnia

Sleep Initiation and Maintenance Disorders

United States
Eli Lilly and Company

Completed

Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD

Attention-Deficit/Hyperactivity Disorder | Comorbid Dyslexia

United States
Eli Lilly and Company

Completed

Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients

Osteoporosis

Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence

Urinary Stress Incontinence

United States

Search clinical trials for: Gallbladder disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations